title: Pharmacology of intraperitoneal CPT-11.
abstract: CPT-11 is clearly one of the most important new anticancer drugs developed in the last few decades, and CPT-11 combined with 5-fluorouracil (5-FU) and leucovorin is considered as reference first-line chemotherapy in the treatment of metastatic colorectal cancer. CPT-11 has a complex pharmacologic profile in vivo, and it needs caboxylesterase-mediated biotransformation to SN-38 before production of its cytotoxic effect. Intraperitoneal administration of CPT-11 has been studied recently in murine models and presented some potential advantage over the intravenous (i.v.) route. Intraperitoneal administration of CPT-11 may be more effective than i.v. administration not only for peritoneal seeding but also for liver metastases. Also, these effects may occur with less toxicity by intraperitoneal administration. Intraperitoneal chemotherapy containing CPT-11 might be an essential option for prevention and treatment of cancerous dissemination of gastrointestinal malignancy.
authors.affiliation: Department of Surgery, Sannou Hospital, 8-10-16, Akasaka Minato-ku, Tokyo 107-0052, Japan. matsui@iuhw.ac.jp
authors.forename: Akira
authors.initials: A
authors.lastname: Matsui
authors.forename: Makoto
authors.initials: M
authors.lastname: Okuda
authors.forename: Kazuyuki
authors.initials: K
authors.lastname: Tsujitsuka
authors.forename: Khoji
authors.initials: K
authors.lastname: Enomoto
authors.forename: Keiichi
authors.initials: K
authors.lastname: Maruyama
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology* / Q000627:therapeutic use; D001682:Biological Availability; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000494:pharmacology* / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D000077146:Irinotecan; D008297:Male; D020714:Maximum Tolerated Dose; D018570:Risk Assessment; D012680:Sensitivity and Specificity
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D000077146:Irinotecan; D002166:Camptothecin